Yatharth Hospital & Trauma Care Services Ltd

Yatharth Hospit. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Yatharth Hospital & Trauma Care Services Ltd

₹ 844 -1.47%
25 Jun 12:28 p.m.
yatharthhospitals.com BSE: 543950 NSE: YATHARTH
About

Incorporated in 2008, Yatharth Hospital and Trauma Care Services Limited is a multi-care hospitals at Noida, Greater Noida, and Noida Extension, Uttar Pradesh.[1]

Key Points

Hospital Portfolio:[1]
Yatharth operates a network of multi-specialty and super-specialty hospitals primarily in North India, focusing on tertiary care, trauma services, and advanced treatments.
The company operates 9 hospitals with
total bed capacity exceeding 2,800 beds
and maintains 12 Centres of Excellence
across specialties. The 80% of beds are
located in metro cities, providing access
to high-demand healthcare markets.[2]

Website BSE NSE
  • Market Cap ₹ 8,132 Cr.
  • Current Price ₹ 844
  • High / Low ₹ 890 / 520
  • Stock P/E 46.4
  • Book Value ₹ 185
  • Dividend Yield 0.00 %
  • ROCE 12.4 %
  • ROE 10.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is expected to give good quarter
  • Company has delivered good profit growth of 57.4% CAGR over last 5 years
  • Company's working capital requirements have reduced from 102 days to 80.1 days

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 12.1% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Hospital

Part of BSE Healthcare Nifty Microcap 250 Nifty Total Market BSE 1000 BSE Hospitals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
144 155 171 167 178 212 218 219 232 258 279 320 342
105 113 126 120 131 158 163 164 175 193 215 246 262
Operating Profit 38 41 46 46 47 54 55 55 57 64 65 74 80
OPM % 27% 27% 27% 28% 26% 25% 25% 25% 25% 25% 23% 23% 23%
1 1 4 5 6 4 3 4 5 9 9 8 7
Interest 6 6 3 0 0 3 2 2 1 0 0 1 5
Depreciation 8 7 7 8 8 11 16 17 13 15 19 24 30
Profit before tax 25 29 40 44 44 43 40 40 49 59 55 57 52
Tax % 31% 35% 30% 33% 13% 29% 23% 24% 20% 28% 25% 25% 14%
17 19 28 29 38 30 31 30 39 42 41 43 45
EPS in Rs 2.64 2.91 3.21 3.44 4.47 3.54 3.61 3.16 4.02 4.36 4.28 4.71 4.93
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
71 78 91 136 215 375 478 635 860 1,207
53 60 71 98 147 263 343 453 635 915
Operating Profit 18 18 20 38 68 112 135 182 225 292
OPM % 25% 24% 22% 28% 32% 30% 28% 29% 26% 24%
0 0 0 0 1 2 3 16 16 26
Interest 6 5 7 20 20 23 23 11 12 7
Depreciation 7 6 8 21 21 28 28 29 57 88
Profit before tax 5 8 5 -2 28 63 88 157 172 224
Tax % 41% 23% 21% -18% 30% 30% 25% 27% 24% 24%
3 6 4 -2 20 44 66 114 131 170
EPS in Rs 2.21 3.75 2.43 -0.79 11.09 6.74 10.04 13.33 13.55 18.20
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: 41%
3 Years: 36%
TTM: 40%
Compounded Profit Growth
10 Years: %
5 Years: 57%
3 Years: 39%
TTM: 36%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: 63%
Return on Equity
10 Years: 14%
5 Years: 14%
3 Years: 12%
Last Year: 10%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 14 16 16 16 16 66 66 86 96 96
Reserves 29 41 39 38 56 51 117 788 1,509 1,684
85 125 175 194 193 264 267 85 12 264
10 11 26 39 43 45 36 60 114 237
Total Liabilities 138 193 257 287 309 426 486 1,019 1,731 2,282
54 53 164 189 251 303 299 442 605 1,250
CWIP 64 110 65 62 0 0 0 0 222 102
Investments 0 0 0 0 0 0 0 0 74 2
20 30 27 36 58 123 187 577 829 928
Total Assets 138 193 257 287 309 426 486 1,019 1,731 2,282

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
25 17 17 39 44 60 64 -3 150 205
-50 -51 -78 -43 -21 -52 -20 -226 -420 -598
26 43 47 5 -19 -1 -18 304 520 254
Net Cash Flow 1 9 -13 1 3 7 26 75 249 -140
Free Cash Flow 24 16 -60 -4 24 21 44 -96 -161 -112
CFO/OP 148% 103% 99% 109% 67% 65% 75% 22% 78% 98%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 58 44 48 45 62 83 82 131 128 113
Inventory Days 47 42 88 72 32
Days Payable 127 106 490 347 171
Cash Conversion Cycle -22 -20 -354 -229 62 83 82 131 128 -26
Working Capital Days 44 29 -75 -89 -18 0 29 118 109 80
ROCE % 8% 6% 7% 18% 26% 27% 24% 14% 12%

Insights

In beta
Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Average Length of Stay (ALOS)
Days

Log in to view insights

Please log in to see hidden values.

Login
Average Revenue Per Occupied Bed (ARPOB)
INR
Bed Capacity
Beds
Bed Occupancy Rate
%
IPD Volumes
Number (000s)
OPD Volumes
Number (000s)

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
66.33% 66.44% 66.54% 66.54% 66.54% 61.44% 61.64% 61.64% 61.64% 55.80% 55.80%
5.42% 2.59% 3.99% 4.90% 6.28% 9.78% 4.45% 4.34% 6.51% 6.18% 5.25%
8.88% 8.81% 9.30% 9.40% 6.97% 11.50% 13.56% 13.52% 8.71% 11.02% 12.00%
19.37% 22.15% 20.15% 19.16% 20.20% 17.27% 20.35% 20.50% 23.16% 27.01% 26.94%
No. of Shareholders 50,11351,74346,56751,91662,61673,25185,66881,44091,43496,22199,117

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls